A drug for advanced ovarian cancer has been approved for use in newly diagnosed patients in England, after a trial showed it could delay progression of the disease for three years. Up to 600 women with a hereditary type of the disease could benefit each ...
from Google Alert - health https://ift.tt/2K6gKT8
via IFTTT
0 comments:
Post a Comment